Healthcare executives expect more IPOs and corporate dealmaking in 2025 [Yahoo! Finance Canada]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance Canada
FRANKFURT (Reuters) - Healthcare executives and investors expect an uptick in initial public offerings and corporate dealmaking in 2025, with geopolitical tensions overtaking funding challenges as the biggest risk to the sector, Jefferies' annual healthcare report showed on Tuesday. WHY IT'S IMPORTANT Healthcare is an active sector for M&A, with deals such as Johnson & Johnson's acquisition of heart device business Shockwave Medical for $13.1 billion announced in April, and KKR's acquisition of a stake in health tech firm Cotiviti in February. With deal activity globally muted in recent months, 72% of the survey's participants expect healthcare M&A levels to be higher in 2025, with around 50% of private equity respondents identifying Europe as a region of opportunity for the sector. Now in its seventh year, the report surveys around 500 senior people from the healthcare sector, spanning institutional and private equity investors, as well as executives at healthcare companies.
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy [Yahoo! Finance]Yahoo! Finance
- Dr Oz nominated to lead CMS despite big pharma ties [Yahoo! Finance]Yahoo! Finance
- Ophthalmic Equipment Market Size to Hit USD 105.20 Billion by 2033 | Straits Research [Yahoo! Finance]Yahoo! Finance
- EcoVadis' Coupa Connector Empowers Procurement Teams to Embed Sustainability into Every Purchasing Decision [Yahoo! Finance]Yahoo! Finance
- Which Is A Better Pick: JNJ Stock Or AbbVie? [Forbes]Forbes
JNJ
Earnings
- 10/15/24 - Beat
JNJ
Sec Filings
- 11/13/24 - Form 13F-HR
- 11/6/24 - Form 25-NSE
- 10/31/24 - Form 4/A
- JNJ's page on the SEC website